EC
NGNE icon

EcoR1 Capital’s Neurogene NGNE Stock Holding History

EcoR1 Capital’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40M Hold
1,271,342
– – 1.94% 10
2026
Q1 		$25.6M Hold
1,271,342
– – 1.09% 13
2025
Q4 		$26.2M Hold
1,271,342
– – 1.19% 16
2025
Q3 		$22M Hold
1,271,342
– – 1.06% 18
2025
Q2 		$19M Hold
1,271,342
– – 1.13% 18
2025
Q1 		$14.9M Hold
1,271,342
– – 0.88% 20
2024
Q4 		$29.1M Hold
1,271,342
– – 1.1% 20
2024
Q3 		$53.3M Hold
1,271,342
– – 1.83% 14
2024
Q2 		$46.3M Hold
1,271,342
– – 1.42% 20
2024
Q1 		$64.7M Hold
1,271,342
– – 1.64% 19
2023
Q4 		$24.6M Buy
+1,271,342
New +$18.2M 0.64% 28
2022
Q1 		– Sell
-43,031
Closed -$4.15M – 94
2021
Q4 		$4.15M Hold
43,031
– – 0.13% 49
2021
Q3 		$6.22M Sell
43,031
-74,909
-64% -$11.5M 0.22% 38
2021
Q2 		$21.8M Sell
117,940
-38,195
-24% -$8.45M 0.81% 27
2021
Q1 		$38.4M Hold
156,135
– – 1.7% 17
2020
Q4 		$44M Sell
156,135
-37,012
-19% -$9.04M 2.37% 16
2020
Q3 		$46.4M Buy
193,147
+16,313
+9% +$3.95M 3.31% 10
2020
Q2 		$58.7M Sell
176,834
-7,826
-4% -$2.04M 4.34% 10
2020
Q1 		$42M Sell
184,660
-11,134
-6% -$2.29M 4.39% 8
2019
Q4 		$48.2M Buy
195,794
+82,500
+73% +$8.22M 4.35% 9
2019
Q3 		$6.46M Hold
113,294
– – 0.82% 24
2019
Q2 		$5.35M Hold
113,294
– – 0.54% 29
2019
Q1 		$6.11M Hold
113,294
– – 0.56% 36
2018
Q4 		$4.89M Hold
113,294
– – 0.49% 40
2018
Q3 		$6.64M Buy
113,294
+55,794
+97% +$3.29M 0.6% 31
2018
Q2 		$3.05M Buy
+57,500
New +$15M 0.29% 29

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EcoR1 Capital's NGNE Position: Q2 2026 in Review

EcoR1 Capital held its Neurogene (NGNE) position steady in Q2 2026 at 1,271,342 shares worth $40M. The position accounts for 1.94% of the portfolio, ranked #10.

EcoR1 Capital first reported a position in NGNE in Q2 2018 and has held it in 26 quarters since. The position peaked at $64.7M in Q1 2024. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • EcoR1 Capital held 1,271,342 shares of Neurogene worth $40M as of Q2 2026.
  • EcoR1 Capital left its Neurogene share count unchanged in Q2 2026.
  • Neurogene made up 1.94% of EcoR1 Capital's portfolio in Q2 2026, its #10 holding.
  • EcoR1 Capital first reported a position in Neurogene in Q2 2018 and has held it in 26 quarters since.
  • EcoR1 Capital's Neurogene position peaked at $64.7M in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on EcoR1 Capital's 13F filing for Q2 2026, filed 14 Aug 2026.